What is Trastuzumab?

Category: Prescription Drugs

Most popular types: Herceptin

false

See also: Docetaxel-carboplatin-trastuzumab-pertuzumab Docetaxel-carboplatin-trastuzumab (TCH) Docetaxel-trastuzumab-pertuzumab (DHP) Doxorubicin-cyclphophosphamide-paclitaxel-trastuzumab (AC-TH) Doxorubicin-cyclphophosphamide-paclitaxel-trastuzumab-pertuzumab (AC-THP) Paclitaxel-trastuzumab-pertuzumab (THP) Paclitaxel-trastuzumab (TH)

Trastuzumab is a monoclonal antibody and antineoplastic agent used as adjuvant treatment of HER-2 overexpressing breast cancer and for the treatment of HER-2 overexpressing metastatic breast cancer.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 3
Moderate 2
Mild 4
None 6

Commonly reported side effects and conditions associated with Trastuzumab

Side effect Patients
Diarrhea 2
Tiredness 2
Decreased sex drive (libido) 1
Fatigue 1
Headaches with eye discomfort 1
Heart ejection fraction rate decreased 1

Show all 12 reported side effects

Why patients stopped taking Trastuzumab

Multiple reasons could be selected

Reason Patients
Course of treatment ended 6
Did not seem to work 1
Doctor's advice 1
Side effects too severe 1
See all 7 patients who've stopped taking Trastuzumab

Duration

Stopped taking Trastuzumab

Duration Patients
1 - 6 months 2
6 months - 1 year 3
2 - 5 years 2
Adherence
Adherence Evaluations
Always 14
Usually 1
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 4
A little hard to take 3
Not at all hard to take 8
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 7
Not specified 8

What people switch to and from

Patients started taking Trastuzumab after stopping:

Treatment Patients
Capecitabine (Xeloda) 1
Last updated:

3 patient evaluations for Trastuzumab

Dec 14, 2014 (Started Mar 20, 2014)

  • Effectiveness
    Major (for breast cancer)
  • Side effects
    Severe (left ventricular systolic dysfunction)
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 440 mg Every 3 Weeks

Dec 13, 2014 (Started Mar 20, 2014)

  • Effectiveness
    Major (for breast cancer)
  • Side effects
    Severe (left ventricular systolic dysfunction)
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 440 mg Every 3 Weeks

Nov 1, 2014 (Started Mar 20, 2014)

  • Effectiveness
    Major (for breast cancer)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 440 mg Every 3 Weeks

Aug 14, 2014 (Started Mar 20, 2014)

  • Effectiveness
    Major (for breast cancer)
  • Side effects
    Severe (left ventricular systolic dysfunction)
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 440 mg Weekly
Advice & Tips: Administered through pic line along with chemo then by injection every 3 weeks after chemo finished. (This 'finds' any stray cancer cells and kills them.) Hercepin quite literally saved my life. My tumour not only shrunk but completely disappeared after 4 doses.

  • 0 helpful marks

Jun 26, 2011 (Started Mar 11, 2009)

  • Effectiveness
    Major (for breast cancer)
  • Side effects
    Moderate (fatigue, headaches with eye discomfort, decreased sex drive (libido))
  • Adherence
    Always
  • Burden
    Somewhat hard to take
Dosage: 60 min Monthly
Advice & Tips: listen to your body and rest when needed
Side effects: fatigue, headaches with eye discomfort, decreased sex drive (libido)

  • 1 helpful mark

Aug 13, 2009 (Started Aug 29, 2008)

  • Effectiveness
    Moderate (for breast cancer)
  • Side effects
    Mild (sinus congestion)
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 580 mL Every Other Week
Cost: < $25 monthly
Side effects: sinus congestion

  • 0 helpful marks
Last updated:
Showing 3 of 3 patient evaluations for Trastuzumab